http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-1107233-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b287fc2ec423dbe49b66a4d8ad03cd1e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 1978-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1985-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1985-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IT-1107233-B
titleOfInvention DERIVATIVES OF 9-HYDROXYELLYPTYCIN SUITABLE FOR THERAPEUTIC USE AND RELATED PRODUCTION PROCESS
abstract Prepn. of ellipticine derivs. of formula (I) and their quat. salts (R1 is H or alkyl; R2 is H, alkyl, aryl, benzyl or benzoyl) comprises (a) condensing 5-methoxyindole with 2,5-hexanedione; (b) demethylating the resulting 6-methoxy-1,4-dimethoxycarbazole to form 6-hydroxy-1,4-dimethylcarbazole; (c) protecting the OH gp. by benzylation or benzoylation; (d) opt. metallating the resulting 6-benz(o)yloxy-1,4-dimethylcarbazole (II) and reacting with alkyl iodide to form the corresp. 9-alkyl-6-benz(o)yloxy-1,4-dimethyl-carbazole (III); (e) formylating (II) or (III) to form the 3-formyl deriv.; (f) condensing with aminoacetaldehyde dimethyl acetal to form the corresp. 3-(2,2-dimethoxyethyliminomethyl) deriv.; (g) cyclising this to form (I) where R1 = H or alkyl and r2 = benzyl or benzoyl; (h) saponifying (I; R2 = benzoyl) or hydrogenolysing (I; R2 = benzyl) to form (I; R2 = H); (i) opt. reacting (I; R2 = H) with an alkyl halide to form the corresp. 2-alkyl quat. halide; and (j) opt. converting this into another quat. salt Cpds. (I) and their quat. salts are antitumour agents (see GB1436080 and 1508388). The process gives high yields of high-purity products.
priorityDate 1978-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415790441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420498418
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408403335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID194331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432301361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415871849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154270220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408096083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13872

Total number of triples: 28.